Mahiuddin Ahmed, Senior VP & Chief Scientific Officer at Y-mAbs Therapeutics, Inc. (YMAB), sold 21,016 shares at $37.64 ($791K) on 2020-05-13, disclosed to the SEC on 2020-05-15.
Open-market sale of $791k YMAB by Senior VP & Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.64 | 10,508 | $396K | 50.0% |
| 2 | $37.64 | 10,508 | $396K | 50.0% |
| Total | $37.64 avg | 21,016 | $791K | 100% |
| Filing → |
| YMAB | SELL | 2020-05-13 | $784K | — | Filing → |